Brent Hiramoto, MD, MPH

Dr. Brent Hiramoto is a gastroenterologist specializing in the treatment of esophageal reflux and motility disorders, eosinophilic esophagitis, anorectal disorders such as fecal incontinence and chronic constipation, and other diverse disorders of gastrointestinal motility and gut-brain interaction. His clinical research interests focus on obesity epidemiology and the effect of obesity on the spectrum of foregut and hindgut motility disorders. He has published in several peer-reviewed journals including Gastroenterology, Clinical Gastroenterology and Hepatology, The American Journal of Gastroenterology, and Alimentary Pharmacology & Therapeutics.

He is a graduate of Northwestern University Feinberg School of Medicine where he obtained his MD. He then completed his residency training at the University of Southern California/Los Angeles General Medical Center. After residency he pursued his fellowship training in gastroenterology as a National Institute of Health (NIH) T32 fellow at the Brigham and Women’s Hospital, a teaching hospital of Harvard Medical School. He completed his MPH at the Harvard T.H. Chan School of Public Health during his fellowship training. He is excited to return to Los Angeles where he plans to pursue his interests in research, teaching, and patient-centered care.

• University of California, Davis: Summa Cum Laude, 2013
• National Institutes of Health: NIH T32 National Research Service Award, 2023
   – 2024
• American Foregut Society: AFS Outstanding Trainee Award, 2024
• American Gastroenterological Association: AGA Fellow Abstract Award, 2024

• University of California, Davis, Davis, CA — BS — Cell Biology
• Northwestern University Feinberg School of Medicine, Chicago, IL — MD — Medicine
• Harvard T.H. Chan School of Public Health, Boston, MA — MPH — Clinical Effectiveness
• University of Southern California/Los Angeles General Medical Center, Los Angeles, CA — Internal Medicine
• Brigham and Women's Hospital, Boston, MA — Gastroenterology, Hepatology, and Endoscopy

• EoE: Which First-Line Treatments Are Most Cost-Effective? (11/27/2024)
• Centrally Distributed Adiposity Linked to Higher Risk of Fecal Incontinence
• Do GLP-1 RAs Significantly Delay Gastric Emptying? Maybe Not (7/10/2024)

• Lipham, John
• Demetriades, Demetrios
• Patterson, Joseph
• Buxbaum, James
• Chandrasoma, Parakrama
• Padula, William